Menu Back toLS18: Guiding RWE Utilization for Regulatory Decision Making in US, EU and Japan
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
18th DIA Japan Annual Meeting 2021
All prices are exclusive of 10% Japanese consumption tax
LS18: Guiding RWE Utilization for Regulatory Decision Making in US, EU and Japan
Yoshiaki Uyama, PhD, RPh
- Director, Office of Medical Informatics and Epidemiology
- Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Gerald J. Dal Pan, MD, MHS
- Director, Office of Surveillance and Epidemiology, CDER
- FDA, United States
- Data Scientist
- European Medicines Agency, Netherlands